Attenuated recombinant mycobacteria useful as immunogens or as vaccine components
AssigneeInstitut Pasteur
InventorsBridgitte Gicquel, Christophe Guilhot, Mary Jackson
Life of this patent
Estimating the term…
Loading patent…
AssigneeInstitut Pasteur
InventorsBridgitte Gicquel, Christophe Guilhot, Mary Jackson
Estimating the term…
This invention provides recombinant mycobacterium strains of pathogenic origin that have been attenuated by the inactivation of a gene coding for a metabolic protein, specifically a gene coding for a protein necessary for the biosynthesis of a purine or a pyrimidine base, and more precisely, the purC gene that codes for an enzyme of the metabolic pathway of purine biosynthesis. The recombinant mycobacterium of this invention have a reduced capacity to propagate in a mammalian host, but remain viable in the host for a period of time sufficient to induce an protective immune response against the natural pathogenic mycobacterium counterpart.
A recombinant mycobacterium strain of pathogenic origin capable of replicating in a macrophage of a host, said strain containing in its chromosome or on a plasmid a counterpart to a gene in the wild type mycobacterium coding for a protein necessary for the biosynthesis of a purine or a pyrimidine base, wherein said counterpart gene in the recombinant mycobacterium has been inactivated by at least one point mutation or by addition, deletion, or substitution of one or more base pairs.
The recombinant mycobacterium strain MYC 1551 (C.N.C.M. No. I-1871).
The recombinant mycobacterium strain MYC 1552 (C.N.C.M. No. I-1872).
A recombinant vector containing SacB gene coding for a levane saccharase enzyme and a nucleotide sequence consisting of a gene coding for a protein necessary for the biosynthesis of a purine or a pyrimidine base that has been inactivated by at least one point mutation or by addition, deletion, or substitution of one or more base pairs.
A purified polynucleotide comprising the SacB gene placed in the neighborhood of a gene coding for a protein necessary for the biosynthesis of a purine or a pyrimidine base that has been inactivated by at least one point mutations or by addition or deletion of one or more base pairs.
A polynucleotide containing all or part of the genome of a mycobacterium strain which is devoid of a wild gene encoding a protein involved in the biosynthesis of a purine or a pyrimidine base.
Dependencies are inferred from the claim text.